ABOUT THIS EVENT

Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, Shoshana Shendelman, Founder & CEO, rang the Closing Bell.